Objective: Prolonged sitting in modern white-collar workplaces has come to be regarded as an independent health risk factor, yet prevailing accounts have tended to anthropomorphise sedentary behaviour as 'the new smoking' and to assert, one-sidedly, that post-work exercise can fully compensate for its harms. Adopting a critical-review stance, this paper re-examines the evidentiary basis, methodological limitations and scholarly controversies surrounding exercise medicine in the sedentary workplace, and proposes a pragmatic integrative prescription framework on that basis.

Methods: Thirty-eight sources, each verified through both Crossref and PubMed, were used as the sole evidentiary base. Evidence strength was graded according to study design (randomised controlled trials, cohort studies, meta-analyses, cross-sectional studies and narrative reviews), and key controversies—whether sedentary behaviour constitutes an independent risk factor, whether high-volume exercise can offset sedentary mortality risk, and the long-term efficacy of standing desks and sitting interruption—were evaluated through a dialogic appraisal of opposing positions.

Results: Epidemiological evidence (Biswas et al., 2015; Diaz et al., 2017) [4, 8] supports positive associations between prolonged uninterrupted sitting and all-cause mortality, cardiovascular mortality and type 2 diabetes; however, such evidence derives largely from self-report or early accelerometer cohort studies, and residual confounding, measurement bias and survivor bias cannot be excluded. Ekelund et al. (2016) [10], employing an individual-participant-data meta-analysis, found that approximately 60–75 minutes of moderate-intensity exercise per week may offset the excess mortality risk associated with sitting for more than eight hours daily—a conclusion that stands in methodological tension with the claim by Biswas et al. (2015) [4], based on study-level pooling, that sedentary behaviour is an independent risk factor. Neither position should be adopted as definitive. The exercise dose–response curve (Arem et al., 2015; Kraus et al., 2019) [1, 18] indicates that 150 minutes of moderate-intensity aerobic exercise per week yields the majority of available benefit; independent and additive effects of resistance training on metabolic syndrome are supported by NHANES data (Dankel, Loenneke, & Loprinzi, 2016) [7], although resistance training alone may not improve metabolic syndrome in older overweight populations without concomitant caloric restriction (Normandin et al., 2017) [21].

Conclusion: Workplace exercise medicine should abandon the binary framework of 'either sedentary or vigorously active' in favour of an integrative strategy comprising frequent daytime interruption, a multimodal post-work prescription and individualised risk assessment. Long-term randomised controlled trials, device-measured cohort studies and cost-effectiveness analyses are urgently required to address the current predominance of observational evidence. It is further argued that clinical and policy language should abandon reductive metaphors such as 'sitting is the new smoking' and instead adopt evidence grading, explicitly classifying recommendations as 'high quality', 'moderate quality' or 'preliminary evidence', so that employers, clinicians and employees can accurately estimate the degree of confidence attaching to each recommendation before committing resources.